BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32533279)

  • 1. Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.
    Kucukseymen S; Neisius U; Rodriguez J; Tsao CW; Nezafat R
    Int J Cardiovasc Imaging; 2020 Oct; 36(10):2027-2038. PubMed ID: 32533279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction.
    Shi K; Yang MX; Huang S; Yan WF; Qian WL; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2021 Sep; 20(1):185. PubMed ID: 34521391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
    Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between diffuse fibrosis assessed by CMR and depressed myocardial strain in different stages of heart failure.
    Zhang Y; Zhang X; Wang Y; Hu X; Wang B; Yang J; Zhao X; Zhang L
    Eur J Radiol; 2023 Jul; 164():110848. PubMed ID: 37156180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.
    Mordi IR; Singh S; Rudd A; Srinivasan J; Frenneaux M; Tzemos N; Dawson DK
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Chirinos JA; Bhattacharya P; Kumar A; Proto E; Konda P; Segers P; Akers SR; Townsend RR; Zamani P
    J Am Heart Assoc; 2019 Feb; 8(4):e011457. PubMed ID: 30764699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.
    Mahmod M; Pal N; Rayner J; Holloway C; Raman B; Dass S; Levelt E; Ariga R; Ferreira V; Banerjee R; Schneider JE; Rodgers C; Francis JM; Karamitsos TD; Frenneaux M; Ashrafian H; Neubauer S; Rider O
    J Cardiovasc Magn Reson; 2018 Dec; 20(1):88. PubMed ID: 30580760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model.
    Han P; Zhang R; Wagner S; Xie Y; Cingolani E; Marban E; Christodoulou AG; Li D
    J Cardiovasc Magn Reson; 2021 Feb; 23(1):8. PubMed ID: 33568177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study.
    Masci PG; Pavon AG; Berchier G; Schwitter J
    BMC Med Imaging; 2019 Jan; 19(1):1. PubMed ID: 30611240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.